What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cardiology
Internal medicine, Cardiology, Cardiomyopathy, Hypertrophic cardiomyopathy and Muscle hypertrophy are his primary areas of study.
The Internal medicine study combines topics in areas such as Endocrinology and Pathology.
His work in Cardiology addresses issues such as Anesthesia, which are connected to fields such as Occlusion.
His research integrates issues of Penetrance, Sudden death, Gene mapping and Bioinformatics in his study of Cardiomyopathy.
His Hypertrophic cardiomyopathy study combines topics from a wide range of disciplines, such as Phenotype, Molecular biology, Sudden cardiac death and Gene expression profiling.
His Muscle hypertrophy study combines topics in areas such as Left ventricular hypertrophy, Pathogenesis, Doppler echocardiography, Wild type and Myocyte.
His most cited work include:
- Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction (1609 citations)
- Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. (817 citations)
- Thrombolysis inMyocardial Infarction (TIMI) Trial, Phase I:acomparison between intravenous tissue plasminogen activator andintravenous streptokinase* (746 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Cardiology, Myocardial infarction, Molecular biology and Hypertrophic cardiomyopathy.
Internal medicine is often connected to Endocrinology in his work.
His studies in Cardiology integrate themes in fields like Anesthesia and Surgery.
His Myocardial infarction study integrates concerns from other disciplines, such as Tissue plasminogen activator and Chest pain.
As a part of the same scientific family, he mostly works in the field of Molecular biology, focusing on Gene and, on occasion, Bioinformatics.
The various areas that Robert Roberts examines in his Hypertrophic cardiomyopathy study include Sudden death, Mutation, Troponin complex, Sudden cardiac death and Myosin.
He most often published in these fields:
- Internal medicine (54.95%)
- Cardiology (42.12%)
- Myocardial infarction (21.25%)
What were the highlights of his more recent work (between 1999-2016)?
- Internal medicine (54.95%)
- Cardiology (42.12%)
- Hypertrophic cardiomyopathy (13.92%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Cardiology, Hypertrophic cardiomyopathy, Cardiomyopathy and Genetics.
His work in Muscle hypertrophy, Sudden cardiac death, Heart disease, Troponin T and Creatine kinase are all subfields of Internal medicine research.
His Muscle hypertrophy research integrates issues from Doppler echocardiography and Left ventricular hypertrophy.
His study looks at the relationship between Troponin T and topics such as Troponin I, which overlap with Unstable angina, Chest pain and Infarction.
In his research on the topic of Hypertrophic cardiomyopathy, Fibrosis, Genotype and Allele is strongly related with Endocrinology.
He combines subjects such as Mitral valve, Penetrance, Pathogenesis and Ventricular outflow tract with his study of Cardiomyopathy.
Between 1999 and 2016, his most popular works were:
- Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction (1609 citations)
- It’s Time for a Change to a Troponin Standard (538 citations)
- Tissue Doppler Imaging Consistently Detects Myocardial Abnormalities in Patients With Hypertrophic Cardiomyopathy and Provides a Novel Means for an Early Diagnosis Before and Independently of Hypertrophy (501 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cardiology
Robert Roberts focuses on Internal medicine, Cardiology, Cardiomyopathy, Hypertrophic cardiomyopathy and Muscle hypertrophy.
His work in Cardiac hypertrophy, Brugada syndrome, Conduction system disease, Ventricular tachycardia and Cardiac rhythm disturbances is related to Internal medicine.
His Cardiology research is multidisciplinary, incorporating perspectives in Scientific evidence and Consensus conference.
His work carried out in the field of Hypertrophic cardiomyopathy brings together such families of science as Penetrance, Endocrinology, Sudden cardiac death and Troponin T.
The concepts of his Endocrinology study are interwoven with issues in Fibrosis and Heart failure.
He has researched Muscle hypertrophy in several fields, including Left ventricular hypertrophy, Bioinformatics, Doppler echocardiography, Mitral valve and Age of onset.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
